Literature DB >> 1845796

Regulated expression of the RB "tumor suppressor gene" in normal lymphocyte mitogenesis: elevated expression in transformed leukocytes and role as a "status quo" gene.

A Yen1, S Chandler, S Sturzenegger-Varvayanis.   

Abstract

Expression of the RB retinoblastoma tumor suppressor gene product is regulated early during the stimulation of normal human peripheral blood lymphocytes, suggesting a regulatory role for the amount of this protein in mitogenesis of normal cells. When normal human peripheral blood lymphocytes were mitogenically stimulated with pokeweed mitogen, bivariate flow cytometric measurements of cellular DNA and RB protein content showed an early decrease in the amount of RB protein per cell, anteceding onset of S phase. A subsequent increase in the amount of RB protein per cell occurred with cell proliferation. Thus the amount of RB protein relative to the total cell mass underwent a biphasic response with mitogenesis. The resulting proliferating cells had a slightly elevated level of RB protein per cell compared to the unstimulated cells. Comparison of other proliferating leukocytes to normal lymphocytes showed that both EBV virally transformed lymphocytes and human promyelocytic leukemia cells (HL-60) had elevated levels of RB protein per cell compared to normal peripheral blood lymphocytes. Mitogenic stimulation or transformation by other means thus is associated with regulation of the amount of RB protein per cell, suggesting a regulatory role for the RB protein in normal cell growth control.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845796     DOI: 10.1016/0014-4827(91)90188-z

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  RB tumor suppressor gene expression responds to DNA synthesis inhibitors.

Authors:  A Yen; S Varvayanis
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

2.  Analysis of the Cycilin D1/p16/pRb Pathway in Parathyroid Adenomas.

Authors:  Eva Cristobal; Begona Arribas; Juan Tardio; Jose A. AIcazar; Juan C. Matinez-Montero; Rafael Carrion; Jose R. Polo; Laura Gil; Marta Azanedo; Jose M. Rojas; Javier Menarguez
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.